Secondary prevention of myocardial infarction--the present state of the ART.
- 3 May 1980
- Vol. 280 (6223), 1128-1130
- https://doi.org/10.1136/bmj.280.6223.1128
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Treatment of the Patient after Myocardial InfarctionNew England Journal of Medicine, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Uric acid: a risk factor for coronary heart disease?Circulation, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- Aspirin Prophylaxis of Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1977
- AN EPIDEMIOLOGICAL STUDY OF RECENT TRENDS IN ECTOPIC PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1975
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974
- IMPAIRED PLATELET/CONNECTIVE-TISSUE REACTION IN MAN AFTER ASPIRIN INGESTIONThe Lancet, 1967
- Inhibition by Adenosine and by 2-Chloroadenosine of the Formation and Embolization of Platelet ThrombiNature, 1964